MatriSys Bioscience, Inc. Alternatives & Competitors

12 companies similar to MatriSys Bioscience, Inc. — Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.

Azitra Inc

Harnessing the microbiome to treat skin disease.

12 Post-IPO Equity $52.84M

Branford, United States

Biotechnology Consumer Goods +1

Dermatology & Skin Surgery Specialists

Expert care for your skin, from acne to anti-aging rejuvenation.

Scottsdale, United States

Biotechnology Health Care +2

Realm Therapeutics, Inc.

2 Post-IPO Equity $26.00M

Malvern, United States

Biotechnology Pharmaceutical

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

Delivering meaningful innovation in medical dermatology.

448 Post-IPO Equity $833.50M

Westlake Village, United...

Biopharma Biotechnology +3

Track all MatriSys Bioscience, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

VYNE Therapeutics Inc.

For every therapeutic challenge, we question traditional assumptions and find better solut...

52 Post-IPO Equity $297.84M

Bridgewater, United State...

Health Care Health and Wellness +1

Compare

Dermira, Inc.

24 Post-IPO Equity $1.13B

Menlo Park, United States

Biopharma Biotechnology +1

Blueberry Therapeutics Ltd

Topical nanomedicines for treating dermatological conditions

3 $17.45M

Macclesfield, United King...

Biotechnology Health Care +1

Vicept Therapeutics, Inc

1 Series A $16.00M

Biopharma Biotechnology

ASLAN Pharmaceuticals

A clinical-stage immunology focused biopharmaceutical company.

44 IPO $218.00M

Singapore, Singapore

Biotechnology Health Care +1

Allecra Therapeutics

Our Mission: Answering the call to action to fight antibiotic resistance

7 Series B $37.00M

Biopharma Biotechnology +1

Y-mAbs Therapeutics, Inc.

Innovative pediatric immunotherapies for Real-life Possibilities

59 Post-IPO Equity $338.80M

New York, United States

Biotechnology Health Care +1

Micreos

Micreos is a biotech company focused on discovering and developing recombinant technology

21 Venture round $59.50M

Baar, Switzerland

Biotechnology Design +1

About MatriSys Bioscience, Inc.

MatriSys Bioscience, Inc. is a clinical stage Specialty Biopharmaceutical Company that focuses on harnessing beneficial bacteria to treat chronic inflammatory skin conditions. The company is targeting the $142 Billion WW dermatology and skin care market by developing therapies for top skin conditions such as Atopic Der...

Business keywords

Specialty Biopharmaceutical Company, Dermatology, Skin Care, Microbiome Therapies, Atopic Dermatitis, Rosacea, Psoriasis, Acne, Skin Infections, Live Biotherapeutic Products, Biopharmaceutical Product Development, Cosmeceutics, Clinical Stage Company, NIH Funded, IP Protection

Frequently Asked Questions

Companies similar to MatriSys Bioscience, Inc. include Azitra Inc, Dermatology & Skin Surgery Specialists, Realm Therapeutics, Inc., Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), VYNE Therapeutics Inc.. They work in Biotechnology and Health Care and share MatriSys Bioscience, Inc.'s focus on dermatology, atopic dermatitis and rosacea.

Bounce Watch lists 12 companies that share MatriSys Bioscience, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches MatriSys Bioscience, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

MatriSys Bioscience, Inc. Profile Azitra Inc Alternatives Dermatology & Skin Surgery Specialists Alternatives Realm Therapeutics, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at MatriSys Bioscience, Inc. on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.